Injective (INJ) is currently priced at $2.97, reflecting a 24-hour change of 2.32%. The price has oscillated between a daily high of $3.02 and a low of $2.87, indicating a relatively tight daily range of $0.15.

Trading volume stands at approximately $39.45 million, contributing to a volume-to-market cap ratio of 13.32%, suggesting healthy market participation. The moving averages reflect a bullish trend, with the 8 SMA at $2.93 showing a 1.20% increase, while the 144 SMA at $2.87 indicates a stronger rise of 3.51%.

The 1-hour RSI is elevated at 73, signaling overbought conditions, which could lead to a pullback in the short term. In contrast, the 7-day RSI at 55 suggests that the asset is in a neutral zone, with some room for upward movement without immediate overextension.

Over the last week, INJ has shown a price increase of approximately 8.37%, and even over the last 30 days, it has gained about 1.47%. This indicates a positive momentum trend, albeit with potential resistance near the recent high of $3.02.

Given the current price action, moving averages, and RSI indicators, INJ shows signs of strength in the mid-term, but the short-term overbought condition could trigger a corrective phase. Therefore, a cautious approach is recommended, advising to Hold positions until clearer signals emerge, as the potential for a pullback exists despite the overall upward trend.